The effect of a geriatric evaluation on treatment decisions for older cancer patients – a systematic review

References

• Taylor C, Munro AJ, Glynne-Jones R, Griffith C, Trevatt P, Richards M, et al. Multidisciplinary team working in cancer: What is the evidence?Br Med J 2010;340:c951.
   PubMed Web of Science ®Google Scholar
• Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, et al. Role of the multidisciplinary team in breast cancer management: Results from a large international survey involving 39 countries. Ann Oncol 2012; 23:853–9.
   PubMed Web of Science ®Google Scholar
• Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Jr., Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341: 2061–7.
   PubMed Web of Science ®Google Scholar
• Bellera C, Praud D, Petit-Moneger A, McKelvie-Sebilau P, Soubeyran P, Mathoulin-Pelissier S. Barriers to inclusion of older adults in randomised controlled clinical trials on Non-Hodgkin’s lymphoma: A systematic review. Cancer Treat Rev 2013;39:812–7.
   PubMed Web of Science ®Google Scholar
• Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003; 21:1383–9.
   PubMed Web of Science ®Google Scholar
• Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S, et al. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005;55: 241–52.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottowa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Available from: www.ohri.ca/programs/clinical_epidemiology/oxford.asp [cited 2012 Nov 21].
   Google Scholar
• Aliamus V, Adam C, Druet-Cabanac M, Dantoine T, Vergnenegre A. Geriatric assessment contribution to treatment decision-making in thoracic oncology. Rev Mal Respir 2011;29:1124–30.
   Web of Science ®Google Scholar
• Aparicio T, Girard L, Bouarioua N, Patry C, Legrain S, Soule JC. A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study. Crit Rev Oncol Hematol 2011;77:63–9.
   PubMed Web of Science ®Google Scholar
• Caillet P, Canoui-Poitrine F, Vouriot J, Berle M, Reinald N, Krypciak S, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 2011;29:3636–42.
   PubMed Web of Science ®Google Scholar
• Chaibi P, Magne N, Breton S, Chebib A, Watson S, Duron J-J, et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol 2011;79:302–7.
   PubMed Web of Science ®Google Scholar
• Extermann M, Meyer J, McGinnis M, Crocker TT, Corcoran MB, Yoder J, et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol 2004;49:69–75.
   PubMed Web of Science ®Google Scholar
• Frennet M, Kerger J, Cornette P, Humblet Y, Lesage V, de Saint-Hubert M. Impact of comprehensive geriatric assessment (CGA) during oncologic treatment in frail elderly patients. Eur Geriatr Med 2011;2:S35.
   Google Scholar
• Girre V, Falcou M-C, Gisselbrecht M, Gridel G, Mosseri V, Bouleuc C, et al. Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?J Gerontol A Biol Sci Med Sci 2008;63:724–30.
   PubMed Web of Science ®Google Scholar
• Horgan AM, Leighl NB, Coate L, Liu G, Palepu P, Knox JJ, et al. Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: A pilot study. Am J Clin 2012;35:322–8.
   Web of Science ®Google Scholar
• Kenis C, Bron D, Libert Y, Decoster L, Van PK, Scalliet P, et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: Results of a prospective multicentric study. Ann Oncol 2013;24: 1306–12.
   PubMed Web of Science ®Google Scholar
• Weltermann A, Koller H. Diagnostic yield of a geriatric assessment and a standardized intervention plan in elderly patients with newly diagnosed cancer: A cohort study. Onkologie 2011;34:228.
   Google Scholar
• Lamb BW, Taylor C, Lamb JN, Strickland SL, Vincent C, Green JS, et al. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: Findings of a national study. Ann Surg Oncol 2013;20: 1408–16.
   PubMed Web of Science ®Google Scholar
• Lamb BW, Sevdalis N, Benn J, Vincent C, Green JS. Multidisciplinary cancer team meeting structure and treatment decisions: A prospective correlational study. Ann Surg Oncol 2013;20:715–22.
   PubMed Web of Science ®Google Scholar
• Wedding U, Kodding D, Pientka L, Steinmetz HT, Schmitz S. Physicians’ judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit Rev Oncol Hematol 2007; 64:1–9.
   PubMed Web of Science ®Google Scholar
• Hoeben KW, van Steenbergen LN, van de Wouw AJ, Rutten HJ, Van Spronsen DJ, Janssen-Heijnen ML. Treatment and complications in elderly stage III colon cancer patients in the Netherlands. Ann Oncol 2013;24: 974–9.
   PubMed Web of Science ®Google Scholar
• Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Frailty screening tools for predicting outcome of a comprehensive geriatric assessment in older cancer patients. Lancet Oncol 2012;13: e437–44.
   Web of Science ®Google Scholar
• Hamaker ME, Vos AG, Smorenburg CH, de Rooij SE, van Munster BC. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older cancer patients. Oncologist 2012;17:1439–49.
   PubMed Web of Science ®Google Scholar
• Hamaker ME, Seynaeve C, Wymenga ANM, van Tinteren H, Nortier JWR, Maartense E, et al. Baseline comprehensive geriatric assessment to predict for toxicity of single- agent chemotherapy in elderly metastatic breast cancer patients: Results from the OMEGA study of the Dutch Breast Cancer Trialists’ Group. J Clin Oncol 2012;30 (suppl abstr 1080):15.
   Google Scholar
• Audisio RA, Osman N, Audisio MM, Montalto F. How do we manage breast cancer in the elderly patients? A survey among members of the British Association of Surgical Oncologists (BASO). Crit Rev Oncol Hematol 2004;52:135–41.
   PubMed Web of Science ®Google Scholar
• National Health Service -National Institute for Clinical Excellence guidances. Available from: www.nice.org.uk [cited 2012 Nov 5].
   Google Scholar
• Mitchell AJ, Bird V, Rizzo M, Meader N. Diagnostic validity and added value of the Geriatric Depression Scale for depression in primary care: A meta-analysis of GDS30 and GDS15. J Affect Disord 2010;125:10–7.
   PubMed Web of Science ®Google Scholar
• Rao AV, Hsieh F, Feussner JR, Cohen HJ. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol A Biol Sci Med Sci 2005; 60:798–803.
   PubMed Web of Science ®Google Scholar
• Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, Defelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012;118:3377–86.
   PubMed Web of Science ®Google Scholar
• Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study. J Clin Oncol 2011;29:3457–65.
   PubMed Web of Science ®Google Scholar